000			01658 a2200445 4500
005			20250516180754.0
264		0	_c20140708
008			201407s 0 0 eng d
022			_a1476-511X
024	7		_a10.1186/1476-511X-12-171 _2doi
040			_aNLM _beng _cNLM
100	1		_aHuang, Yue Ye
245	0	0	_aNonalcoholic fatty liver disease: molecular pathways and therapeutic strategies. _h[electronic resource]
260			_bLipids in health and disease _cNov 2013
300			_a171 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650	0	4	_aCurcumin _xtherapeutic use
650	0	4	_aFatty Acid Synthase, Type I _xgenetics
650	0	4	_aFatty Liver _xdrug therapy
650	0	4	_aFibric Acids _xtherapeutic use
650	0	4	_aForkhead Box Protein O1
650	0	4	_aForkhead Transcription Factors _xgenetics
650	0	4	_aGene Expression Regulation
650	0	4	_aHumans
650	0	4	_aLipid Metabolism _xdrug effects
650	0	4	_aLiver _xdrug effects
650	0	4	_aMitochondria _xdrug effects
650	0	4	_aNon-alcoholic Fatty Liver Disease
650	0	4	_aPPAR gamma _xgenetics
650	0	4	_aPeroxisomes _xdrug effects
650	0	4	_aPregnane X Receptor
650	0	4	_aProtective Agents _xtherapeutic use
650	0	4	_aReceptors, Cytoplasmic and Nuclear _xgenetics
650	0	4	_aReceptors, Steroid _xgenetics
650	0	4	_aThiazolidinediones _xtherapeutic use
700	1		_aGusdon, Aaron M
700	1		_aQu, Shen
773	0		_tLipids in health and disease _gvol. 12 _gp. 171
856	4	0	_uhttps://doi.org/10.1186/1476-511X-12-171 _zAvailable from publisher's website
999			_c23245918 _d23245918